DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Campath (Alemtuzumab) - Cytomegalovirus Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cytomegalovirus Infection (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include cytomegalovirus infection. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Campath side effects in female

Reported by a consumer/non-health professional from Germany on 2012-07-06

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, bid
    Start date: 2009-07-23

Campath
    Dosage: 20 mg, qd
    Start date: 2009-07-07

Campath
    Dosage: 30 mg, qd
    Start date: 2009-08-06
    End date: 2009-08-06

Campath
    Dosage: 30 mg, qd
    Start date: 2009-09-11
    End date: 2009-10-22

Campath
    Dosage: 10 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-20

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-21

Cyclophosphamide
    Dosage: 1250 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-07

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-07

Doxorubicin HCL
    Dosage: 80 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-21

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-20

Filgrastim
    Dosage: 3000 iu, unk
    Start date: 2009-07-26
    End date: 2009-08-27

Filgrastim
    Dosage: unk on days 4 through 13 of course 5
    Start date: 2009-08-20

Filgrastim
    Dosage: unk on days 4 through 12 of course 6
    Start date: 2009-09-08

Filgrastim
    Dosage: unk on days 4, 5, 6 of course 1
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Filgrastim
    Dosage: unk on days 4 through 15 of course 2
    Start date: 2009-07-07

Filgrastim
    Dosage: unk on days 4 through 8 and day 13 of course 3
    Start date: 2009-07-23

Filgrastim
    Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
    Start date: 2009-08-06

Filgrastim
    Dosage: 30000 iu, qd
    Start date: 2009-09-11
    End date: 2009-09-19

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-06-23

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-09-11

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-07

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-08-06
    End date: 2009-08-10

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2009-09-08
    End date: 2009-09-08

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-06-23

Vincristine
    Dosage: 1 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-20

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-23

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-07

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-21

Vincristine

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva



Possible Campath side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28

Patient: female

Reactions: Cytomegalovirus Viraemia, Cytomegalovirus Infection, Peripheral Sensory Neuropathy, Pathogen Resistance

Drug(s) suspected as cause:
Campath
    Dosage: on d8, 12 of admission
    Indication: Transplant Rejection

Cidofovir
    Dosage: received 3 doses
    Indication: Cytomegalovirus Viraemia

Foscarnet
    Indication: Cytomegalovirus Viraemia

Ganciclovir
    Indication: Cytomegalovirus Viraemia

Leflunomide
    Dosage: 20mg daily maintenance

Leflunomide
    Dosage: 100mg daily for 3d; then 20mg daily
    Indication: Cytomegalovirus Viraemia

Methylprednisolone
    Dosage: 500mg daily
    Indication: Transplant Rejection

Prednisolone
    Administration route: Oral
    Indication: Transplant Rejection

Tacrolimus
    Indication: Immunosuppressant Drug Therapy

Valganciclovir
    Dosage: 900mg daily for 5m
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Valganciclovir
    Administration route: Oral



Possible Campath side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: 60 year old male

Reactions: Graft Versus Host Disease, Tuberculosis, Pseudomembranous Colitis, Cytomegalovirus Infection, Epstein-Barr Viraemia, Pancytopenia, Lymphoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-29
    End date: 2011-08-01

Campath
    Dosage: unk
    Start date: 2011-08-11

Certican
    Dosage: 0.25 mg, bid
    Administration route: Oral

Certican
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-06-01
    End date: 2011-08-01

Mabthera
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-01
    End date: 2011-07-01

Mabthera
    Dosage: unk

Myfortic
    Indication: Immunosuppression

Myfortic
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-01
    End date: 2011-06-01

Neoral
    Dosage: 100 mg, qd
    Indication: Immunosuppression

Neoral
    Dosage: 160 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-03-01
    End date: 2011-06-01

Prograf
    Dosage: unk
    Indication: Graft Versus Host Disease in Skin



Possible Campath side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-09

Patient: female

Reactions: Death, Pneumonia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Fludara

Other drugs received by patient: Trimethoprim; Cyclosporine; Sulphamethoxazole; Anti-Thymocyte Globulin Equine NOS; Fluconazole; Acyclovir; Mycophenolate Mefetil; Busulfan; Corticosteroids



Possible Campath side effects in 68 year old female

Reported by a physician from Germany on 2012-02-06

Patient: 68 year old female

Reactions: Death, Pneumonia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Haematological Malignancy

Fludara
    Dosage: unk
    Indication: Haematological Malignancy

Other drugs received by patient: Anti-Thymocyte Globulin Equine NOS; Sulphamethoxazole; Cyclosporine; Mycophenolate Mofetil; Trimethoprim; Fluconazole; Corticosteroids; Acyclovir; Busulfan



Possible Campath side effects in 68 year old

Reported by a physician from Germany on 2011-11-02

Patient: 68 year old

Reactions: Death, Bronchopulmonary Aspergillosis, Acute Graft Versus Host Disease, Cytomegalovirus Infection, Cerebral Toxoplasmosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Acyclovir; Trimethoprim; Carmustine; Cyclosporine; Melphalan Hydrochloride; Mycophenolate Mofetil; Anti-Thymocyte Globulin NOS; Sulphamethoxazole; Fludarabine; Fluconazole



Possible Campath side effects in 70 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-27

Patient: 70 year old male, weighing 67.9 kg (149.4 pounds)

Reactions: Dyspnoea, Anaemia, Muscular Weakness, Hypoaesthesia, Fall, Paraesthesia, Fatigue, Dehydration, Platelet Count Decreased, Cytomegalovirus Infection, Blood Pressure Decreased, Immobile, Infestation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
(Rituximab)
    Dosage: 758 mg, not reported
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2010-12-27
    End date: 2011-05-18

Campath
    Dosage: 30 mg, tiw x 18 weeks, subcutaneous
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-29
    End date: 2011-09-14

Cyclophosphamide
    Dosage: 1212 mg
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2010-12-27
    End date: 2011-05-18

Nipent
    Dosage: 8 mg
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2010-12-27
    End date: 2011-05-18



Possible Campath side effects in 55 year old

Reported by a physician from Germany on 2011-10-14

Patient: 55 year old

Reactions: Death, Bronchopulmonary Aspergillosis, Cytomegalovirus Infection, Systemic Inflammatory Response Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Trimethoprim; Fludara; Sulphamethoxazole; Fluconazole; Cyclophosphamide; Mycophenolate Mofetil; Acyclovir; Cyclosporine



Possible Campath side effects in 48 year old

Reported by a physician from Germany on 2011-10-14

Patient: 48 year old

Reactions: Death, Bronchopulmonary Aspergillosis, Sepsis, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Sulphamethoxazole; Mycophenolate Mofetil; Cyclosporine; Trimethoprim; Fluconazole; Acyclovir; Corticosteroids; Busulfan; Cyclophosphamide



Possible Campath side effects in 42 year old

Reported by a physician from Germany on 2011-10-14

Patient: 42 year old

Reactions: Erythema Infectiosum, Acute Graft Versus Host Disease, Chronic Graft Versus Host Disease, Organising Pneumonia, Death, Cytomegalovirus Infection, Acute Respiratory Distress Syndrome, Systemic Inflammatory Response Syndrome, Pneumonia Respiratory Syncytial Viral

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Carmustine; Cyclosporine; Sulphamethoxazole; Fludara; Trimethoprim; Acyclovir; Melphalan Hydrochloride; Mycophenolate Mofetil; Fluconazole



Possible Campath side effects in 19 year old

Reported by a physician from Germany on 2011-10-14

Patient: 19 year old

Reactions: Pneumonia, Graft Versus Host Disease, Epidermolysis, Intestinal Haemorrhage, Death, Systemic Inflammatory Response Syndrome, Cytomegalovirus Infection, Escherichia Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Cyclosporine; Mycophenolate Mofetil; Busulfan; Cyclophosphamide; Corticosteroids; Fluconazole; Anti-Thymocyte Globulin NOS; Daclizumab; Trimethoprim; Sulphamethoxazole; Acyclovir



Possible Campath side effects in 55 year old female

Reported by a physician from Germany on 2011-10-14

Patient: 55 year old female

Reactions: Death, Pneumonia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Tacrolimus; Cyclosporine; Trimethoprim; Sulphamethoxazole; Mycophenolate Mofetil; Cyclophosphamide; Anti-Thymocyte Globulin NOS; Etanercept; Daclizumab; Fluconazole; Rituximab; Acyclovir; Corticosteroids



Possible Campath side effects in 68 year old

Reported by a physician from Germany on 2011-10-14

Patient: 68 year old

Reactions: Bronchopulmonary Aspergillosis, Death, Acute Graft Versus Host Disease, Cytomegalovirus Infection, Cerebral Toxoplasmosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Trimethoprim; Carmustine; Acyclovir; Melphalan Hydrochloride; Anti-Thymocyte Globulin NOS; Mycophenolate Mofetil; Sulphamethoxazole; Fludarabine Phosphate; Fluconazole; Cyclosporine



Possible Campath side effects in 68 year old female

Reported by a physician from Germany on 2011-10-13

Patient: 68 year old female

Reactions: Death, Pneumonia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Busulfan; Cyclosporine; Fluconazole; Acyclovir; Mycophenolate Mofetil; Sulphamethoxazole; Corticosteroids; Fludara; Anti-Thymocyte Globulin NOS; Trimethoprim



Possible Campath side effects in 37 year old

Reported by a physician from Germany on 2011-10-13

Patient: 37 year old

Reactions: Death, Pneumonia, Sepsis, Cytomegalovirus Infection, Chronic Graft Versus Host Disease, Liver Transplant

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Mycophenolate Mofetil; Sulfamethoxazole W; Acyclovir; Busulfan; Anti-Thymocyte Globulin NOS; Cyclophosphamide; Fluconazole; Cyclosporine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017